Complications and risk factors of transrectal ultrasound guided needle biopsies of the prostate evaluated by questionnaire

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 5, 2008, Pages 474-478

  Ecke, Thorsten H ^a   Gunia, Sven ^a   Bartel, Peter ^a   Hallmann, Steffen ^a   Koch, Stefan ^a   Ruttloff, Jürgen ^a  

^a HELIOS Klinikum Bad Saarow   (Germany)

Author keywords

Biopsy; Bleeding; Postoperative complications; Prostate; Urinary tract infection

Indexed keywords

ACETYLSALICYLIC ACID; CIPROFLOXACIN; GENTAMICIN;

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; BODY TEMPERATURE; CANCER SCREENING; DYSURIA; FEVER; HEMATURIA; HOSPITALIZATION; HUMAN; INFECTION RATE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; QUESTIONNAIRE; RISK FACTOR; TRANSRECTAL ULTRASOUND GUIDED NEEDLE BIOPSY; URINALYSIS; URINARY TRACT INFECTION; URINE RETENTION;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; SURGERY, COMPUTER-ASSISTED;

EID: 50649106657     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.12.003     Document Type: Article

References (37)

1. Astraldi A. Diagnosis of cancer of the prostate; biopsy by rectal route. Urol Cutan Rev 41 (1937) 421-427
2. Hodge K.K., McNeal J.E., Terris M.K., et al. Random systematic vs. directed ultrasound guided transrectal biopsies of the prostate. J Urol 142 (1989) 71-74
3. Naughton C.K., Smith D.S., Humphrey P.A., et al. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: A retrospective study. Urology 52 (1998) 808-813
4. Levine M.A., Ittman M., Melamed J., et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159 (1998) 471-475
5. Stricker H.J., Ruddock L.J., Wan J., et al. Detection of nonpalpable prostate cancer. A mathematical and laboratory model. Br J Urol 71 (1993) 43-46
6. Coplen D.E., Andriole G.L., Yuan J.J., et al. The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia. J Urol 146 (1991) 75-77
7. Cooner W.H., Mosley B.R., Rutherford Jr. C.L., et al. Clinical application of transrectal ultrasonography and prostate specific antigen in the search of prostate cancer. J Urol 139 4 (1988) 758-761
8. Cooner W.H., Mosley B.R., Rutherford Jr. C.L., et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination, and prostate specific antigen. J Urol 143 6 (1990) 1146-1152
9. Hodge K.K., McNeal J.E., and Stamey T.A. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 142 (1989) 66-70
10. Ostroff E.B., Almario J., and Kramer H. Transrectal needle method for biopsy of the prostate: Review of 90 cases. Am Surg 41 (1975) 659-661
11. Crawford E.D., Haynes Jr. A.L., Story M.W., et al. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 127 3 (1982) 449-451
12. Gustafsson O., Norming U., Nyman C.R., et al. Complications following combined transrectal aspiration and core biopsy of the prostate. Scand J Urol Nephrol 24 (1990) 249-251
13. Thompson P.M., Talbot R.W., Packham D.A., et al. Transrectal biopsy of the prostate and bacteraemia. Br J Surg 67 2 (1980) 127-128
14. Thompson P.M., Pryor J.P., Williams J.P., et al. The problem of infection after prostatic biopsy: The case for the transperineal approach. Br J Urol 54 6 (1982) 736-740
15. Partin A.W., and Oesterling J.E. Clinical use of prostatic specific antigen: update 1994. J Urol 152 (1994) 1358-1368
16. Brawer M.K. Prostate-specific antigen: Critical issues. Urology 44 (1994) 9
17. Hudson M.A., Bahnson R.R., and Catalona W.J. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 142 (1989) 1011-1017
18. Stamey T.A., Yang N., Hay A.R., et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317 (1987) 909
19. Aus G., Ahlgren G., Bergdahl S., et al. Infection after transrectal core biopsies of the prostate risk factors and antibiotic prophylaxis. Br J Urol 77 6 (1996) 851-855
20. Aus G., Hermansson C.G., Hugosson J., et al. Transrectal ultrasound examination of the prostate: Complications and acceptance by patients. Br J Urol 71 4 (1993) 457-459
21. Sieber P.R., Rommel F.M., Agusta V.E., et al. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 157 (1997) 2199-2200
22. Raaijmakers R., Kirkels W.J., Roobol M.J., et al. Complication rate and risk factors of 5,802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urol 60 5 (2002) 826-830
23. Rodriguez L.V., and Terris M.K. Risks and complications of transrectal ultrasound guided prostate needle biopsy: A prospective study and review of the literature. J Urol 160 (1998) 2115-2120
24. Deliveliotis C., John V., Louras G., et al. Multiple transrectal ultrasound guided prostatic biopsies: morbidity and tolerance. Int Urol Nephrol 31 (1999) 681-686
25. Djavan B., Waldert M., Zlotta A., et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: Results of a prospective European prostate cancer detection study. J Urol 166 (2001) 856-860
26. Enlund A.L., and Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic therapy: A prospective study in 415 cases. Br J Urol 70 (1997) 777-780
27. Manseck A., Guhr K., Froehner M., et al. Morbidity and discomfort of ten-core biopsy of the prostate evaluated by questionnaire. Urol Int 66 (2001) 197-200
28. Peyromaure M., Ravery V., Messas A., et al. Pain and morbidity of an extensive prostate 10-biopsy protocol: A prospective study in 289 patients. J Urol 167 (2002) 218-221
29. Rietbergen J.B.W., Boeken-Kruger A.E., Kranse R., et al. Complications of transrectal ultrasound (TRUS) guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population based screening program. Urology 49 (1997) 875-880
30. Ashby E.C., Rees M., and Dowding C.H. Prophylaxis against systemic infection after transrectal biopsy for suspected prostatic carcinoma. Br Med J 2 (1978) 1263-1264
31. Davison P., and Malament M. Urinary contamination as a result of transrectal biopsy of the prostate. J Urol 105 4 (1971) 545-546
32. Fawcett D.P., Eykyn S., and Bultitude M.I. Urinary tract infection following trans-rectal biopsy of the prostate. Br J Urol 47 6 (1975) 679-681
33. Vallancien G., Prapotnich D., Veillon B., et al. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 146 5 (1991) 1308-1312
34. Breslin J.A., Turner B.L., Faber R.B., et al. Anaerobic infection as a consequence of transrectal prostatic biopsy. J Urol 120 (1978) 502-503
35. Norberg M., Holmberg L., Haggman M., et al. Determinants of complications after multiple transrectal core biopsies of the prostate. Eur Radiol 6 (1996) 457-461
36. Irani J., Fournier F., Bon D., et al. Patients tolerance of transrectal ultrasound-guided biopsy of the prostate. Br J Urol 79 (1997) 608-610
37. Clements R., Aideyan O.U., Griffiths G.J., et al. Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol 47 (1993) 125-126